Skip to main content
aap Implantate AG logo

aap Implantate AG — Investor Relations & Filings

Ticker · AAQ1 ISIN · DE000A3H2101 LEI · 39120001TRQTQ01LPP57 F Manufacturing
Open in API
Filings indexed 854 across all filing types
Latest filing 2021-01-29 Declaration of Voting R…
Country DE Germany
Listing F AAQ1

About aap Implantate AG

https://www.aap.de/

aap Implantate AG is a medical technology company that operates as a pure player in the field of traumatology. The company develops, manufactures, and markets implants for the treatment of bone fractures. Its core product is the LOQTEQ® system, a comprehensive portfolio of anatomical plates and screws featuring a patented technology that combines fracture compression with angle-stable locking. This titanium-based system is designed to cover a broad spectrum of indications in upper and lower extremity trauma surgery. In addition to its established product line, aap is developing next-generation platform technologies, including antibacterial silver-coated implants to reduce infection risk and resorbable magnesium implants intended to eliminate the need for secondary removal surgeries.

Recent filings

Filing Released Lang Actions
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly mentions the 'Publication of total number of voting rights' and details a 'Type of capital measure' (Conditional capital increase). This relates directly to the company's capital structure and shareholder rights regarding voting power. While it involves capital, the core announcement is about the total voting rights count, which is a specific regulatory disclosure. Given the options, 'Capital/Financing Update' (CAP) is plausible, but the announcement is specifically about the total number of voting rights resulting from a capital measure, which is a very specific disclosure often tied to capital changes. However, since the document details a 'Conditional capital increase' and reports the resulting 'New total number of voting rights', it fits best under 'Capital/Financing Update' (CAP) as it directly concerns the capital structure change and its immediate effect on voting rights, or potentially 'Share Issue/Capital Change' (SHA). Given the focus on the *total voting rights* resulting from a capital measure, CAP is a strong fit for financing activities, but SHA specifically covers capital changes. Since the text explicitly mentions 'Conditional capital increase' and the resulting total voting rights, SHA (Share Issue/Capital Change) is the most precise fit for reporting the outcome of a capital structure adjustment.
2021-01-29 English
FY/2020: Sales of EUR 9.3 million in Corona year in upper half of guidance - dynamic sales growth in USA (+41%); significant sales growth and positive EBITDA in trauma business planned for FY/2021
Earnings Release Classification · 100% confidence The document is a press release dated January 21, 2021, detailing preliminary financial results for the fiscal year 2020 (FY/2020) and providing an outlook for FY/2021. Key phrases include 'Preliminary Results/Forecast', 'Sales of EUR 9.3 million in Corona year', and 'Outlook FY/2021'. This content structure—announcing preliminary figures and future guidance—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K) nor a comprehensive Interim Report (IR), but rather the initial announcement of key results. FY 2020
2021-01-21 English
aap completes Management Board transition to support growth and value creation
Board/Management Information Classification · 100% confidence The document is a news release dated December 18, 2020, announcing changes to the Management Board of aap Implantate AG, specifically the re-appointment of the CEO and CFO, and the appointment of a new COO. This content directly relates to changes in senior management personnel. Based on the provided definitions, this falls under 'Board/Management Information' (Code: MANG). It is not an earnings release (ER), a full annual report (10-K), or a general regulatory filing (RNS), as it addresses a specific management transition.
2020-12-18 English
aap's successful restructuring paves way for follow-up steps in multilayered financing for growth and value creation
Capital/Financing Update Classification · 99% confidence The document is a news release dated December 8, 2020, disseminated via DGAP, which is a service for corporate news and regulatory announcements. The content explicitly discusses the company's successful restructuring and the evaluation of 'various further financing measures for the first quarter of 2021,' including equity-based transactions and out-licensing. This directly relates to capital structure changes and fundraising activities. Since it is an announcement detailing plans for future financing (capital increase, etc.) rather than a formal regulatory filing like a 10-K or a specific financial report (IR, ER), the most appropriate category is 'Capital/Financing Update' (CAP). It is not a short announcement of a report release (RPA/RNS) because the core content is the financing strategy itself.
2020-12-08 English
Q3 and 9M/2020: aap restructuring shows clear successes in challenging COVID-19 times
Earnings Release Classification · 100% confidence The document text explicitly details the financial performance for the 'Q3 and 9M/2020' period, including key metrics like Sales, EBITDA, Gross Margin, and Cash Flow comparisons against the previous year (Q3/2019 and 9M/2019). It also provides an 'Outlook' for the full year 2020. This structure—comprehensive financial review for a specific interim period (nine months) and the preceding quarter—is characteristic of an Interim/Quarterly Report. Although it is presented as a DGAP-News announcement, the content itself is the detailed financial report, not just a brief announcement of its publication. Therefore, it aligns best with the Interim / Quarterly Report (IR) definition, rather than the Earnings Release (ER) which is typically just highlights, or the Report Publication Announcement (RPA) which would only announce the release. 9M 2020
2020-10-30 English
aap Implantate AG: Significant year-on-year improvement in Q3/2020 earnings with almost balanced EBITDA - EBITDA forecast for the full year raised
Earnings Release Classification · 100% confidence The document is an 'Ad-hoc' announcement dated October 26, 2020, disclosing preliminary figures for Q3/2020 and raising the full-year EBITDA forecast. It explicitly states, 'A more detailed press release on the key developments in the third quarter and first nine months of 2020 will be issued later this week.' This indicates the document itself is a preliminary results announcement, not the comprehensive report (like 10-K or IR). The content focuses on key financial highlights (EBITDA, sales) and forecast changes. This aligns perfectly with the definition of an Earnings Release (ER). It is not a full transcript (CT), a full quarterly report (IR), or just an announcement of a report (RPA), as it contains the actual preliminary results and forecast change. 9M 2020
2020-10-26 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.